Search Results 1191-1200 of 16090 for jhajjarcancer

  1. Mayo Clinic Comprehensive Cancer Center — Research

    Success of cancer immunotherapy is limited by the ability of solid tumors to evade local and systemic antitumoral immune responses.

  2. Study of Lenzilumab and Axicabtagene Ciloleucel in Subjects with Relapsed or Refractory Large B-cell Lymphoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. Shelagh A. Cofer, M.D. - Mayo Clinic Faculty Profiles

    Learn about the research interests of Shelagh A. Cofer, M.D., a pediatric otorhinolaryngologist at Mayo Clinic studying ear, nose and throat diseases in ...

  4. Mayo Clinic Comprehensive Cancer Center — Research

    The treatment for postmenopausal women diagnosed with hormone receptor positive (HR+) metastatic breast cancer (mBr) includes endocrine therapy However, ...

  5. Focus Areas - Psychiatric Genomics and Pharmacogenomics Program - Mayo Clinic Research

    The Psychiatric Genomics and Pharmacogenomics Program at Mayo Clinic studies links between genetics, bipolar disorder, addiction and alcohol use disorder to ...

  6. Below are current clinical trials. 2790 studies in Mayo Clinic Comprehensive Cancer Center — Research (all studies, either open or closed). Filter this list of ...

  7. Overview - Hepatobiliary Cancer Laboratory - Mayo Clinic Research

    The Hepatobiliary Cancer Lab of Lewis R. Roberts, M.B., Ch.B., Ph.D., at Mayo Clinic targets liver cancer genes and works to prevent hepatitis B and C ...

  8. Study to Examine the Patient Experience of Living with Undercared for Chronic Suffering - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. Mayo Clinic Comprehensive Cancer Center — Research

    Erlotinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as bevacizumab, can block tumor ...

  10. Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients with High-Risk Stage III-IV Melanoma that has been Removed by Surgery - Mayo Clinic

    Monoclonal antibodies, such as ipilimumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor ...